viral
infect
play
import
role
human
diseas
recent
outbreak
advent
global
eas
travel
underscor
prevent
critic
issu
safeguard
public
health
despit
progress
made
immun
drug
develop
mani
virus
lack
prevent
vaccin
effici
antivir
therapi
often
beset
gener
viral
escap
mutant
thu
identifi
novel
antivir
drug
critic
import
natur
product
excel
sourc
discoveri
minireview
summar
antivir
effect
report
sever
natur
product
herbal
medicin
virus
respons
number
human
pathogenes
includ
cancer
sever
hardtocur
diseas
complex
syndrom
includ
alzheim
diseas
type
diabet
hepatocellular
carcinoma
associ
viral
infect
moreov
due
increas
global
travel
rapid
urban
epidem
outbreak
caus
emerg
reemerg
virus
repres
critic
threat
public
health
particularli
prevent
vaccin
antivir
therapi
unavail
exampl
includ
recent
emerg
dengu
viru
influenza
viru
measl
viru
sever
acut
respiratori
syndrom
sar
viru
west
nile
viru
outbreak
date
howev
mani
virus
remain
without
effect
immun
antivir
drug
licens
clinic
practic
situat
exacerb
potenti
develop
drugresist
mutant
especi
use
tabl
antivir
effect
sever
natur
product
herbal
medicin
specif
virus
coronaviru
saikosaponin
b
c
saikosaponin
b
inhibit
viral
attach
penetr
stage
lycori
radiata
activ
compon
lycorin
artemisia
annua
pyrrosia
lingua
lindera
aggregata
sarscov
unclear
phenol
compound
isati
indigotica
sarscov
sarscov
proteas
inhibitor
amentoflavon
isol
torreya
nucifera
sarscov
sarscov
proteas
inhibitor
myricetin
scutellarein
sarscov
sarscov
helicas
inhibitor
houttuynia
cordata
water
extract
sarscov
sarscov
proteas
inhibitor
viral
polymeras
inhibitor
coxsackieviru
aqueou
ethanol
extract
ocimum
basilicum
well
compon
compound
linalool
apigenin
ursol
acid
cvb
ursol
acid
interfer
viral
infect
replic
raoulic
acid
raoulia
australi
cvb
unclear
herbal
prescript
xiaochaihutang
cvb
induct
type
interferon
respons
bupleurum
kaoi
cvb
induct
type
interferon
respons
dengu
viru
baicalein
virucid
activ
extracellular
viru
imped
viral
adsorpt
onto
host
cell
inhibit
viral
replic
post
entri
quercetin
inhibit
viral
replic
viral
attach
entri
process
narasin
disrupt
viral
protein
synthesi
without
affect
viral
rna
replic
marin
seawe
extract
denv
serotyp
canistrocarpu
cervicorni
padina
gymnospora
palisada
perfor
caulerpa
racemosa
effect
act
earli
stage
viral
infect
chebulag
acid
punicalagin
isol
terminalia
chebula
retz
inactiv
free
viru
particl
inhibit
earli
viral
entri
includ
attach
penetr
phase
affect
viral
celltocel
transmiss
enteroviru
aqueou
ethanol
extract
ocimum
basilicum
well
compon
compound
linalool
apigenin
ursol
acid
ursol
acid
inhibit
viral
infect
replic
raoulic
acid
raoulia
australi
unclear
gallic
acid
woodfordia
fruticosa
flower
unclear
epigallocatechin
gallat
green
tea
interfer
viral
replic
via
modul
cellular
redox
environ
hepat
b
viru
isochlorogen
acid
laggera
alata
unclear
amid
alkaloid
piper
longum
unclear
dehydrocheilanthifolin
isol
corydali
saxicola
unclear
herbal
prescript
xiaochaihutang
inhibit
product
hbv
express
hbeag
saikosaponin
c
bupleurum
speci
saikosaponin
c
inhibit
hbeag
express
hbv
dna
replic
ethanol
extract
polygonum
cuspidatum
sieb
et
zucc
unclear
curcumin
viral
transcript
suppressor
via
downregul
coactiv
hepat
c
viru
standard
extract
silybum
marianum
antivir
effect
partli
due
enhanc
ifnassoci
jakstat
pathway
flavonolignan
silybum
marianum
silymarin
antivir
effect
probabl
relat
antioxid
function
flavonolignan
curcumin
hcv
replic
inhibitor
via
suppress
pathway
contd
inhibit
viral
entri
affect
fluiditi
hcv
envelop
inhibit
viral
entri
griffithsin
prevent
infect
inhibit
viral
celltocel
transmiss
ladanein
inhibit
viral
entri
tellimagrandin
rosa
rugosa
flo
hcv
invas
inhibitor
chebulag
acid
punicalagin
isol
terminalia
chebula
retz
inactiv
free
viru
particl
interfer
viral
bind
fusion
postinfect
celltocel
spread
herp
simplex
viru
entepiafzelechin
epiafzelechin
isol
cassia
javanica
inhibit
viral
replic
herbal
prescript
longdanxiegantan
inactiv
viru
particl
herbal
prescript
yinchenhaotang
inactiv
viru
particl
hippomanin
isol
phyllanthu
urinaria
unclear
geraniin
isol
phyllanthu
urinaria
unclear
excoecarianin
isol
phyllanthu
urinaria
inactiv
viru
particl
chebulag
acid
punicalagin
isol
terminalia
chebula
retz
cell
surfac
gagcompetitor
inhibit
viral
entri
bind
fusion
postinfect
celltocel
spread
meliacin
deriv
melia
azedarach
infect
mous
model
induc
product
houttuynoid
ae
houttuynia
cordata
unclear
aqueou
extract
rhododendron
ferrugineum
l
inhibit
viral
adsorpt
penetr
blackberri
extract
inhibit
viral
replic
exhibit
virucid
activ
proanthocyanidinenrich
extract
myrothamnu
flabellifolia
welw
inhibit
viral
adsorpt
penetr
step
glucoevatromonosid
digitali
lanata
inhibit
viral
protein
synthesi
human
immunodefici
viru
artemisia
annua
artemisia
afra
unclear
tricycl
coumarin
stem
bark
calophyllum
brasiliens
inhibit
viral
replic
acut
chronic
infect
suppress
activ
melittin
inactiv
viru
disrupt
viral
lipid
envelop
influenza
viru
elderberri
liquid
extract
sambucu
nigra
ifa
ifb
unclear
extract
pelargonium
sidoid
root
ifa
inhibit
viral
entri
releas
inhibit
viral
hemagglutin
na
activ
aqueou
extract
dandelion
taraxacum
officinal
ifa
inhibit
viral
np
rna
level
polymeras
activ
spirooliganon
b
root
illicium
oligandrum
ifa
unclear
chalcon
glycyrrhiza
inflat
ifa
ifa
na
inhibitor
xanthon
polygala
karensium
ifa
ifa
na
inhibitor
homoisoflavonoid
caesalpinia
sappan
ifa
ifa
na
inhibitor
contd
cov
envelop
positivesens
singlestrand
rna
ssrna
viru
belong
coronavirida
famili
cov
famili
consist
sever
speci
caus
upper
respiratori
tract
gastrointestin
infect
mammal
bird
human
mainli
caus
common
cold
complic
includ
pneumonia
sar
occur
known
human
cov
hcov
includ
wide
known
sever
acut
respiratori
syndrom
coronaviru
sarscov
caus
global
threat
high
mortal
world
health
organ
design
sixth
type
hcov
infect
identifi
middl
east
respiratori
syndrom
coronaviru
merscov
associ
high
fatal
specif
treatment
cov
infect
prevent
vaccin
still
explor
thu
situat
reflect
need
develop
effect
antivir
prophylaxi
treatment
cov
infect
previous
report
saikosaponin
b
c
natur
occur
triterpen
glycosid
isol
medicin
plant
bupleurum
spp
heteromorpha
spp
scrophularia
scorodonia
exert
antivir
activ
upon
cochalleng
viru
natur
compound
effect
prevent
earli
stage
infect
includ
viral
attach
penetr
extract
lycori
radiata
artemisia
annua
pyrrosia
lingua
lindera
aggregata
also
document
display
antisarscov
effect
screen
analysi
use
hundr
chines
medicin
herb
natur
inhibitor
sarscov
enzym
helicas
proteas
identifi
well
includ
myricetin
scutellarein
phenol
compound
isati
indigotica
torreya
nucifera
anticov
natur
medicin
includ
water
extract
houttuynia
cordata
observ
exhibit
sever
antivir
mechan
sarscov
inhibit
viral
proteas
block
viral
rnadepend
rna
polymeras
activ
natur
product
evalu
propos
mechan
refer
herbal
prescript
shengmagegentang
antivir
effect
may
modul
tnfa
stimul
cheroke
remedi
spicebush
unclear
biflavonoid
rhu
succedanea
garcinia
multiflora
well
methyl
ether
acet
unclear
calcium
spirulan
bluegreen
alga
spirulina
platensi
unclear
crotolu
durissu
terrificu
snake
venom
probabl
virucid
target
viral
entri
extract
zanthoxylum
chalybeum
warburgia
ugandensi
unclear
olinia
rochetiana
olkirenyi
warburgia
ugandensi
osokonoi
neutral
viru
particl
stem
root
extract
cajanu
cajan
unclear
chebulag
acid
punicalagin
isol
terminalia
chebula
retz
inactiv
free
viru
particl
interfer
viral
bind
fusion
postinfect
celltocel
spread
respiratori
syncyti
viru
chebulag
acid
punicalagin
isol
terminalia
chebula
retz
inactiv
free
viru
particl
inhibit
earli
viral
entri
includ
attach
penetr
phase
affect
viral
celltocel
transmiss
uncinosid
b
selaginella
uncinata
unclear
genkwanol
b
genkwanol
c
stelleranol
extract
radix
wikstroemia
unclear
flavon
leav
lophatherum
gracil
unclear
herbal
prescript
shengmagegentang
inhibit
viral
attach
intern
step
stimul
secret
cimicifuga
foetida
l
inhibit
viral
attach
intern
step
stimul
secret
cimicifugin
cimicifuga
foetida
l
inhibit
viral
attach
intern
step
stimul
secret
resveratrol
rsvinduc
inflamm
reduc
virusinduc
airway
inflamm
via
downregul
level
rsv
infect
coxsackieviru
cv
includ
subgroup
cva
b
cvb
member
picornavirida
famili
nonenvelop
positivesens
ssrna
viru
typic
transmit
fecalor
rout
contact
respiratori
secret
symptom
infect
includ
mild
ill
fever
malais
rash
common
coldlik
present
sever
case
may
result
diseas
central
nervou
system
includ
asept
mening
enceph
paralysi
cva
best
known
one
caus
agent
hand
foot
mouth
diseas
hfmd
young
children
unfortun
vaccin
specif
antivir
therapi
avail
prevent
cv
infect
diseas
caus
nevertheless
drug
discov
natur
product
herb
tradit
decoct
shown
promis
develop
therapeut
cv
infect
aqueou
extract
ethanol
extract
bioactiv
compound
includ
linalool
apigenin
ursol
acid
popular
culinarymedicin
herb
ocimum
basilicum
sweet
basil
observ
possess
antivir
activ
particular
ursol
acid
interfer
replic
postinfect
raoulic
acid
raoulia
australi
also
report
potenti
antivir
agent
sever
cvb
subtyp
mechan
effect
unclear
addit
previous
report
medicin
prescript
xiaochaihutang
tang
major
compon
herb
bupleurum
kaoi
inhibit
infect
via
induct
type
interferon
respons
find
suggest
type
interferon
induc
may
help
control
cvb
infect
could
explor
treatment
strategi
denv
envelop
positivesens
ssrna
viru
flavivirida
famili
promin
arboviru
southeast
asia
denv
transmit
mosquito
bite
typic
aed
aegypti
four
serotyp
viru
exist
caus
dengu
fever
clinic
manifest
denv
infect
includ
inapparentmild
febril
present
classic
dengu
fever
fever
headach
myalgia
joint
pain
nausea
vomit
skin
rash
lifethreaten
hemorrhag
diseas
specif
dengu
hemorrhag
feverdengu
shock
syndrom
dhfdss
sever
case
despit
old
diseas
current
immun
therapeut
option
avail
prevent
control
denv
infect
sever
limit
manag
dengueassoci
diseas
consist
prevent
viral
infect
mosquito
control
reliev
symptom
infect
individu
develop
prophylactictherapeut
treatment
denv
infect
use
natur
product
may
help
address
current
limit
flavon
baicalein
exampl
exert
potent
activ
denv
adsorpt
host
postentri
viral
replic
addit
sever
natur
product
quercetin
narasin
well
marin
seawe
extract
observ
possess
signific
antidenv
properti
recent
report
chebulag
acid
punicalagin
two
hydrolys
tannin
isol
terminalia
chebula
broadspectrum
antivir
agent
sever
virus
includ
denv
specif
chebulag
acid
punicalagin
directli
inactiv
free
denv
particl
interfer
attach
fusion
event
earli
viral
entri
identif
natur
viral
inhibitor
could
help
develop
therapeut
denv
infect
reduc
risk
dhfdss
member
picornavirida
famili
possess
positivesens
ssrna
genom
nonenvelop
ordinarili
transmit
fecalor
rout
transmiss
respiratori
droplet
also
possibl
one
major
caus
hfmd
children
sometim
associ
sever
neurolog
diseas
fatal
transmiss
rate
children
year
age
typic
high
endem
area
sever
outbreak
occur
past
decad
medic
prevent
vaccin
present
develop
palli
care
use
amelior
symptom
nevertheless
sever
natur
product
herbal
medicin
shown
possess
inhibitori
activ
infect
extract
pure
constitu
basilicum
effect
block
infect
replic
addit
raoulic
acid
previous
mention
inhibitor
cvb
also
suppress
gallic
acid
woodfordia
fruticosa
flower
also
observ
exert
activ
final
epigallocatechin
gallat
green
tea
identifi
interfer
replic
via
modul
cellular
redox
environ
without
effici
medic
treatment
prevent
control
infect
studi
identifi
novel
antivir
enteroviru
encourag
hbv
prototyp
viru
hepadnavirida
famili
envelop
viru
possess
relax
circular
partial
doublestrand
dna
dsdna
genom
hbv
caus
hepat
b
infect
transmit
exposur
blood
bodi
fluid
contain
viru
although
spontan
recoveri
common
follow
acut
hepat
b
medic
recommend
chronic
infect
risk
develop
cirrhosi
hepatocellular
carcinoma
hcc
develop
hbv
vaccin
nationwid
hepat
b
vaccin
program
endem
countri
taiwan
help
control
hbv
infect
well
reduc
incid
childhood
hcc
despit
exist
prevent
vaccin
present
hbvinfect
popul
includ
area
vaccin
program
unavail
remain
risk
endstag
liver
diseas
therapeut
treatment
hbv
includ
nucleotid
nucleosid
analog
lamivudin
adefovir
tenofovir
telbivudin
entecavir
well
immun
modul
pegyl
interferona
pegifna
howev
erad
hbv
host
prove
difficult
persist
infect
establish
situat
aggrav
risk
select
drugresist
viral
mutant
treatment
failur
nonrespond
potenti
futur
viral
reactiv
therefor
antihbv
drug
discoveri
still
matter
import
support
current
therapi
hepat
b
manag
program
treat
current
million
carrier
global
extens
studi
conduct
past
decad
identifi
antihbv
agent
natur
product
herbal
medicin
thoroughli
cover
elsewher
exampl
isochlorogen
acid
laggera
alata
amid
alkaloid
piper
longum
dehydrocheilanthifolin
corydali
saxicola
report
antihbv
activ
also
previous
demonstr
antivir
effect
herbal
prescript
xiaochaihutang
tang
saikosaponin
bupleurum
speci
ethanol
extract
polygonum
cuspidatum
sieb
et
zucc
hbv
vitro
anoth
exampl
curcumin
shown
inhibit
hbv
gene
replic
express
downregul
peroxisom
proliferatoractiv
receptor
gamma
coactiv
coactiv
hbv
transcript
novel
antihbv
inhibitori
agent
discov
futur
studi
also
evalu
potenti
combin
treatment
standard
nucleotidenucleosid
analog
ifnabas
therapi
manag
hepat
b
hcv
envelop
flaviviru
possess
positivesens
ssrna
transmiss
hcv
mainli
occur
bloodtoblood
contact
intraven
inject
blood
transfus
variou
exposur
blood
contamin
tattoo
pierc
razor
toothbrush
share
etc
due
highli
mutabl
natur
hcv
prevent
vaccin
yet
avail
infect
becom
persist
result
estim
million
carrier
worldwid
may
progress
endstag
liver
diseas
includ
cirrhosi
hcc
present
standard
care
consist
parenter
pegifna
plu
oral
ribavirin
soon
incorpor
new
proteas
inhibitor
boceprevir
telaprevir
combin
therapi
howev
sever
obstacl
remain
current
method
therapeut
treatment
hcv
includ
limit
efficaci
certain
viral
genotyp
inevit
select
drugresist
mutant
seriou
sideeffect
high
cost
medic
patient
adher
issu
challeng
difficulttotreat
popul
nonrespond
liver
transplant
patient
thu
continu
develop
antihcv
agent
necessari
meet
shortcom
variou
natur
product
explor
antivir
effect
hcv
infect
silybum
marianum
also
known
milk
thistl
silymarin
flavonolignan
demonstr
exert
antihcv
activ
vitro
sever
clinic
evalu
shown
promis
effect
reduc
viral
load
curcumin
identifi
potenti
inhibitor
hcv
replic
potenti
suppress
sterol
regulatori
element
bind
akt
pathway
recent
neg
effect
hcv
entri
demonstr
natur
compound
observ
prevent
hcv
entri
well
includ
griffithsin
ladanein
tellimagrandin
similarli
recent
identifi
hydrolyz
tannin
chebulag
acid
punicalagin
potent
inhibitor
hcv
entri
two
tannin
inactiv
free
viru
particl
prevent
viral
attach
penetr
host
cell
disrupt
postinfect
celltocel
transmiss
hcv
sinc
immun
hcv
present
unavail
discoveri
novel
antihcv
entri
inhibitor
could
help
develop
prevent
therapiesmeasur
hepat
c
herp
simplex
viru
type
type
envelop
dsdna
virus
belong
herpesvirida
famili
hsv
infect
usual
caus
mucocutan
lesion
occur
oralperior
typic
genit
commonli
area
well
bodi
site
hsv
caus
lifelong
infect
establish
sensori
neuron
reactiv
variou
stimuli
includ
sunlight
fever
immunosuppress
menstruat
stress
transmiss
hsv
result
contact
infect
lesion
occur
via
vertic
transmiss
infect
mother
newborn
although
diseas
usual
selflimit
treat
antivir
sever
complic
occur
particularli
neonat
immunosuppress
individu
lead
risk
blind
keratoconjunct
potenti
fatal
mening
enceph
vaccin
avail
hsv
current
drug
erad
latent
hsv
infect
although
primari
recurr
infect
control
nucleosid
analog
acyclovir
penciclovir
prodrug
develop
drugresist
viru
becom
seriou
problem
especi
immunocompromis
patient
thu
identifi
novel
antihsv
agent
act
differ
mechan
crucial
clinic
manag
hsv
previous
report
sever
natur
product
herbal
medicin
inhibit
hsv
infect
replic
instanc
entepiafzelechin
epiafzel
chin
extract
cassia
javanica
inhibit
replic
herbal
prescript
longdanxiegantan
yinchenhaotang
tang
possess
broad
effici
diminish
infect
hippomanin
geraniin
excoecarianin
isol
phyllanthu
urinaria
potent
imped
hsv
infect
addit
also
identifi
hydrolyz
tannin
chebulag
acid
punicalagin
cell
surfac
glycosaminoglycan
gag
competitor
inhibit
entri
celltocel
spread
also
multitud
virus
employ
gag
initi
attach
receptor
infect
host
cell
chebulag
acid
punicalagin
observ
target
glycoprotein
interact
gag
turn
prevent
associ
cell
surfac
gag
well
subsequ
bind
receptor
inhibitori
effect
shown
cellfre
viru
viral
attach
fusion
stage
intercellular
junction
spread
mediat
glycoprotein
thu
tannin
demonstr
effici
entri
inhibitor
similar
effect
observ
anoth
herpesviru
human
cytomegaloviru
well
sever
virus
known
engag
gag
entri
besid
natur
product
tradit
decoct
mention
plethora
natur
antihsv
agent
also
identifi
meliacin
deriv
melia
azedarach
observ
stimul
tumor
necrosi
factoralpha
tnfa
product
reduc
shed
improv
virusinduc
pathogenesi
mous
vagin
model
herpet
infect
houttuynoid
ae
flavonoid
isol
houttuynia
cordata
found
exhibit
potent
activ
similarli
aqueou
extract
rhododendron
ferrugineum
l
blackberri
extract
proanthocyanidinenrich
extract
myrothamnu
flabellifolia
welw
report
inhibit
infect
anoth
exampl
glucoevatromonosid
cardenolid
digitali
lanata
suggest
alter
cellular
electrochem
gradient
block
propag
cell
addit
natur
product
marin
environ
repres
whole
biodivers
mani
alga
spong
observ
contain
activ
metabolit
antihsv
activ
abund
natur
antihsv
agent
discov
provid
novel
pharmacolog
activ
viru
could
explor
potenti
applic
manag
hsv
infect
hiv
lentiviru
retrovirida
famili
envelop
viru
character
target
immun
cell
infect
revers
transcript
ssrna
genom
integr
host
chromosom
dna
transmiss
hiv
occur
via
exchang
viruscontain
blood
bodi
fluid
sexual
contact
share
contamin
needlessharp
instrument
childbirth
well
breastfeed
hiv
caus
agent
acquir
immunodefici
syndrom
aid
progress
failur
immun
system
due
tlymphocyt
deplet
lead
manifest
lifethreaten
opportunist
infect
malign
date
aid
result
million
death
current
million
hivinfect
individu
estim
million
newli
diagnos
case
annual
despit
nearli
year
research
sinc
discoveri
present
effect
prevent
vaccin
cure
hiv
infect
high
antigen
divers
multipl
mechan
viru
employ
subvert
recognit
human
immun
system
made
prophylactictherapeut
manag
hiv
infect
difficult
nevertheless
develop
highli
activ
antiretrovir
therapi
haart
consist
cocktail
nucleosid
analognonnucleosid
reversetranscriptas
inhibitor
dramat
decreas
morbid
mortal
associ
hivaid
howev
still
press
need
altern
treatment
strategi
hiv
infect
due
drug
resist
problem
treatmentassoci
toxic
patient
adher
restrict
access
resourcepoor
area
exhaust
list
natur
product
evalu
antiretroviralantihiv
activ
recent
review
moreov
mani
marin
natur
product
antihiv
activ
also
identifi
search
novel
therapeut
aid
viru
briefli
mention
exampl
crude
extract
artemisia
annua
artemisia
afra
recent
report
potenti
antihiv
medicin
calophyllum
speci
known
contain
sever
coumarin
observ
exert
inhibitori
effect
hiv
recent
tricycl
coumarin
deriv
stem
bark
calophyllum
brasiliens
shown
inhibit
hiv
replic
vitro
model
suppress
nuclear
factorkappa
b
activ
anoth
novel
antihiv
agent
small
peptid
melittin
activ
compon
bee
venom
nanoformul
melittin
demonstr
possess
robust
effici
captur
inactiv
hiv
particl
disrupt
viral
lipid
envelop
base
discoveri
made
far
recent
progress
identifi
natur
antivir
hiv
yield
potenti
novel
therapeut
could
play
import
role
overcom
current
urgenc
antihivaid
therapi
influenza
b
c
virus
ifa
ifb
ifc
envelop
negativesens
ssrna
virus
classifi
orthomyxovirida
famili
virus
caus
respiratori
infect
yield
symptom
includ
fever
headach
sore
throat
sneez
muscl
joint
pain
develop
sever
potenti
fatal
condit
pneumonia
ifa
epidem
wide
host
rang
includ
bird
human
well
mammal
wherea
ifb
seem
natur
infect
human
ifc
less
frequent
encount
isol
human
swine
influenza
viru
infect
produc
consider
morbid
human
estim
death
occur
annual
due
season
epidem
major
pandem
number
observ
rise
million
death
case
spanish
flu
despit
avail
vaccin
base
predict
circul
strain
influenza
virus
known
continu
evolv
hemagglutinin
ha
neuraminidas
na
envelop
protein
variat
render
preexist
circul
antibodi
earlier
exposur
immun
ineffect
neutral
viru
henc
make
host
vulner
infect
furthermor
potenti
risk
crossspeci
transmiss
host
adapt
influenza
virus
anim
human
result
highli
pathogen
strain
also
rais
concern
anoth
issu
widespread
develop
drug
resist
observ
first
gener
antiinfluenza
medic
specif
ion
channel
blocker
amantadin
rimantadin
resist
strain
current
approv
neuraminidas
inhibitor
prevent
releas
matur
influenza
virus
includ
oseltamivir
zanamivir
also
alreadi
appear
due
drug
resist
problem
rapid
evolut
influenza
virus
occurr
sever
recent
outbreak
eg
sophist
antivir
strategi
urgent
need
prevent
control
potenti
pandem
emerg
influenza
strain
sever
natur
product
examin
effect
influenza
standard
elderberri
sambucu
nigra
liquid
extract
exert
vitro
antivir
effect
ifa
ifb
well
respiratori
bacteri
pathogen
licens
commerci
extract
pelargonium
sidoid
root
inhibit
entri
ifa
impair
viral
hemagglutin
well
neuraminidas
activ
improv
symptom
influenzainfect
mice
aqueou
extract
dandelion
taraxacum
officinal
imped
ifa
infect
decreas
polymeras
activ
well
nucleoprotein
np
rna
level
spirooliganon
b
root
illicium
oligandrum
exhibit
potent
antiifa
activ
multitud
secondari
plant
metabolit
also
identifi
potenti
influenza
na
inhibitor
recent
one
includ
chalcon
glycyrrhiza
inflata
xanthon
polygala
karensium
homoisoflavonoid
caesalpinia
sappan
explor
natur
antiinfluenza
agent
clinic
applic
help
broaden
drug
portfolio
prophylact
therapeut
treatment
potenti
flu
epidem
pandem
mv
envelop
negativesens
ssrna
viru
morbilliviru
genu
paramyxovirida
famili
mv
caus
measl
acut
infect
respiratori
system
character
fever
conjunct
cough
runni
nose
nausea
gener
macular
red
rash
bodi
complic
occur
lead
pneumonia
enceph
potenti
fatal
although
highli
contagi
contact
respiratori
droplet
airborn
aerosol
immun
measl
given
threepart
mmr
vaccin
measl
mump
rubella
made
mv
infect
rel
uncommon
develop
countri
recoveri
usual
follow
uncompl
mv
infect
current
specif
antivir
treatment
measl
despit
exist
success
vaccin
mv
viru
remain
major
killer
children
develop
countri
anoth
seriou
problem
reemerg
measl
vaccin
popul
nonimmun
adult
highlight
outbreak
recent
year
issu
emphas
mv
medic
import
need
develop
suitabl
drug
therapi
effort
made
identifi
natur
product
inhibit
mv
includ
number
east
southeast
asian
tradit
medicin
herbal
decoct
shengmagegentang
tang
cheroke
remedi
spicebush
plant
biflavonoid
isol
rhu
succedanea
garcinia
multiflora
calcium
spirulan
bluegreen
alga
spirulina
platensi
crotalu
durissu
terrificu
snake
venom
sever
rwandan
ugandan
medicin
plant
extract
among
other
previous
review
addit
sever
tradit
dietari
herb
addit
maasai
includ
olinia
rochetiana
olkirenyi
warburgia
ugandensi
osokonoi
report
inhibit
mv
infect
vitro
anoth
exampl
plant
extract
cajanu
cajan
recent
suggest
possess
antimv
activ
although
bioactiv
constitu
remain
elus
two
tannin
chebulag
acid
punicalagin
also
show
robust
effect
mv
infect
particularli
inactiv
viru
particl
interrupt
bind
fusion
phase
viral
entri
prevent
postinfect
viru
spread
chebulag
acid
punicalagin
could
therefor
serv
potenti
entri
inhibitor
mv
rsv
envelop
negativestrand
ssrna
viru
paramyxovirida
famili
ubiquit
pathogen
lead
caus
viral
lower
respiratori
tract
infect
infant
children
virtual
children
becom
infect
rsv
age
year
rsv
infect
typic
result
mild
symptom
healthi
adult
lead
bronchiol
pneumonia
infant
immunocompromis
individu
moreov
infant
rsv
infect
pose
potenti
risk
childhood
asthma
although
rsv
caus
sever
diseas
young
infant
continu
plagu
human
throughout
cours
lifetim
immun
rsv
gener
suffici
provid
protect
consequ
human
prone
repeat
reinfect
lifethreaten
elderli
immunocompromis
current
immun
rsv
unavail
therapi
exist
treatment
rsv
infect
palivizumab
monoclon
antibodi
rsv
fusion
protein
ribavirin
nucleosid
analogu
moder
effect
limit
efficaci
thu
need
develop
novel
antivir
manag
rsv
infect
sever
plantderiv
natur
product
demonstr
exhibit
antirsv
activ
uncinosid
b
two
chromon
glycosid
isol
selaginella
uncinata
potent
inhibit
rsv
infect
three
biflavonoid
name
genkwanol
b
genkwanol
c
stelleranol
extract
radix
wikstroemia
observ
display
antivir
activ
rsv
sever
flavon
leav
lophatherum
gracil
shown
reduc
rsv
infect
cytopath
effectreduct
assay
previous
also
identifi
sever
antirsv
natur
medicin
includ
herbal
prescript
shengmagegentang
tang
use
treat
respiratori
diseas
major
compon
herb
cimicifuga
foetida
l
well
plantassoci
bioactiv
compound
cimicifugin
addit
broadspectrum
antivir
activ
demonstr
hydrolyz
tannin
chebulag
acid
punicalagin
also
includ
antivir
effect
rsv
infect
specif
two
tannin
inactiv
rsv
particl
also
block
viral
entryrel
event
includ
bind
fusion
interestingli
chebulag
acid
punicalagin
howev
ineffect
rsv
postinfect
spread
could
abrog
event
mv
anoth
paramyxoviru
besid
target
viral
infect
natur
product
may
help
improv
rsvinduc
respiratori
tract
symptom
includ
airway
inflamm
resveratrol
one
exampl
observ
downregul
level
prevent
airway
inflammationhyperrespons
rsv
infect
mice
suggest
applic
reduc
rsvinduc
airway
symptom
mani
virus
remain
without
prevent
vaccin
effect
antivir
treatment
erad
viral
diseas
appear
difficult
nonetheless
natur
product
serv
excel
sourc
biodivers
discov
novel
antivir
reveal
new
structureact
relationship
develop
effect
protectivetherapeut
strategi
viral
infect
mani
natur
product
herbal
ingredi
observ
possess
robust
antivir
activ
discoveri
help
develop
deriv
therapeut
lead
eg
glycyrrhetin
acid
deriv
novel
antihbv
agent
acetoxim
deriv
mediterranean
mollusk
hexaplex
trunculu
inhibitor
caffeic
acid
deriv
new
type
influenza
na
antagonist
discoveri
chebulag
acid
punicalagin
capabl
inhibit
entri
sever
virus
due
gagcompet
properti
could
help
develop
broadspectrum
antivir
prevent
control
viral
pathogen
mani
studi
domain
preliminari
explor
character
bioactiv
ingredi
defin
underli
mechan
well
assess
efficaci
potenti
applic
vivo
encourag
order
help
develop
effect
antivir
treatment
furthermor
addit
studi
also
examin
possibl
combin
therapi
natur
agent
standard
therapeut
multitarget
therapi
may
help
reduc
risk
gener
drugresist
virus
believ
natur
product
continu
play
import
role
contribut
antivir
drug
develop
